MEGAKARYON CORP.

History

YearDetail
2011 Megakaryon was founded to commercialize the research results of Prof. Nakauchi's research teams.
2013 The company opened a Kyoto Lab at the Kyoto University Hospital Campus.
2015 The company commenced collaborative research with Harvard University (Boston Children's Hospital).
2023 Sysmex Corp. acquired Megakaryon Corp., making it its consolidated subsidiary. Through this acquisition, Sysmex aims to commercialize high-quality and highly safe platelet preparations derived from human iPS cells.
AI Sentiment